Clinical Trials in Drug Development Overview
inVentiv Health Clinical is a drug development services company with a global infrastructure that allows us to conduct any clinical trial, from a single local study to programs spanning multiple continents. For pharmaceutical, biotechnology, generic drug, and medical device companies of all sizes around the world, inVentiv Health Clinical can help you transform promising ideas into commercial reality.
inVentiv Health Clinical can conduct your Phase I – IIa clinical trials, in virtually all therapeutic areas, quickly and efficiently in healthy and special populations. Our extensive database ensures rapid study participant recruitment.
For Phase IIb – III clinical trials we offer a full range of services including biostatistics, data management, project management, study monitoring, patient recruitment, and global safety and pharmacovigilance. Our expertise in oncology, cardiology, neuroscience, infectious disease, pain, dermatology, ophthalmology, and other therapeutic areas ensure that our project team professionally executes your program.
Following approval, inVentiv Health Clinical's Late Stage experts can guide you through the design and execution of a post-approval program, while addressing the needs and concerns of patients, providers, payers, and government regulators. We offer the vision and clarity to help you make smart and profitable decisions for your post-marketing programs.
During your study, high quality and timely bioanalytical results are critical. inVentiv Health Clinical scientists have the expertise to solve the most complex bioanalytical problems, for small or large molecules, using techniques from GC, GC/MS/MS, and LC/MS/MS to ELISAs, RIAs, immunoassays, and biomarkers.
We provide skilled individuals and teams across all therapeutic and functional areas to meet your staffing needs.